EMEA-002844-PIP01-20
Key facts
| Active substance |
Autologous selected renal cells
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0265/2021
|
| PIP number |
EMEA-002844-PIP01-20
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Treatment of chronic kidney disease
|
| Route(s) of administration |
Percutaneous use
|
| Contact for public enquiries |
ProKidney
Tel. +1 336-462-2293 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|